Our demonstration of reversal of deficits in synaptic connectivity due to alterations in HSPG function in MPS I strongly supports further development of gene and cell therapies to introduce missing enzyme activity in other LDs and thereby restore neurological function by normalizing the brain connectome. Here, SDC2 is linked to Scheie syndrome.